APA

Demyanets S., Speidl W. S., Tentzeris I., Jarai R., Katsaros K. M., Farhan S., Krychtiuk K. A., Wonnerth A., Weiss T. W., Huber K. & Wojta J. (20150120). Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome. : PloS one.

Chicago

Demyanets Svitlana, Speidl Walter S, Tentzeris Ioannis, Jarai Rudolf, Katsaros Katharina M, Farhan Serdar, Krychtiuk Konstantin A, Wonnerth Anna, Weiss Thomas W, Huber Kurt and Wojta Johann. 20150120. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome. : PloS one.

Harvard

Demyanets S., Speidl W. S., Tentzeris I., Jarai R., Katsaros K. M., Farhan S., Krychtiuk K. A., Wonnerth A., Weiss T. W., Huber K. and Wojta J. (20150120). Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome. : PloS one.

MLA

Demyanets Svitlana, Speidl Walter S, Tentzeris Ioannis, Jarai Rudolf, Katsaros Katharina M, Farhan Serdar, Krychtiuk Konstantin A, Wonnerth Anna, Weiss Thomas W, Huber Kurt and Wojta Johann. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome. : PloS one. 20150120.